Table 1.
Period | Total Births | Candidates for Palivizumab |
Non- Residents | Candidates for Nirsevimab | Treated with Nirsevimab | No Prophylaxis | Coverage |
---|---|---|---|---|---|---|---|
01/05/2023 18/12/2023 | 461 | 13 | 0 | 448 | 292 | 156 | 65% |
19/12/2023 15/02/2024 | 95 | 3 | 3 | 89 | 77 | 12 | 86% |
Total | 556 | 16 | 3 | 537 | 369 | 168 | 69% |